Inventor
LANGLEY DAVID R
US49 patents
⚠️ This page may combine multiple inventors who share the name “LANGLEY DAVID R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
33 patentsUS7659270B2Feb 9, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO72 citations98
US9308236B2Apr 12, 2016
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO51 citations96
US7759495B2Jul 20, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO41 citations96
US7745636B2Jun 29, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO53 citations94
US7741347B2Jun 22, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO52 citations94
US7704992B2Apr 27, 2010
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO58 citations94
US9879046B2Jan 30, 2018
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO17 citations93
US8642025B2Feb 4, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO12 citations92
US7534792B2May 19, 2009
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO30 citations92
US10633419B2Apr 28, 2020
Immunomodulators
BRISTOL MYERS SQUIBB CO7 citations84
US10143746B2Dec 4, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO9 citations84
US9856292B2Jan 2, 2018
Immunomodulators
BRISTOL MYERS SQUIBB CO12 citations84
US9850225B2Dec 26, 2017
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO13 citations84
US9227961B2Jan 5, 2016
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO6 citations84
US8846023B2Sep 30, 2014
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO7 citations84
US10538555B2Jan 21, 2020
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO8 citations83
US9006235B2Apr 14, 2015
Inhibitors of human immunodeficiency virus replication
BRISTOL MYERS SQUIBB CO8 citations83
US7879855B2Feb 1, 2011
Pyrrolotriazine kinase inhibitors
BRISTOL MYERS SQUIBB CO10 citations83
US9850283B2Dec 26, 2017
Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions
BRISTOL MYERS SQUIBB CO12 citations82
US11578054B2Feb 14, 2023
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO2 citations73
US11358988B2Jun 14, 2022
Immunomodulators
BRISTOL MYERS SQUIBB CO2 citations73
US10358463B2Jul 23, 2019
Immunomodulators
BRISTOL MYERS SQUIBB CO7 citations73
US10144706B2Dec 4, 2018
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO7 citations73
US9018390B2Apr 28, 2015
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO4 citations73
US10882844B2Jan 5, 2021
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO4 citations72
US11952434B2Apr 9, 2024
Immunomodulators
BRISTOL MYERS SQUIBB CO0 citations62
US11066445B2Jul 20, 2021
Immunomodulators acting as antagonists of PD-1
BRISTOL MYERS SQUIBB CO2 citations62
US10988507B2Apr 27, 2021
Immunomodulators
BRISTOL MYERS SQUIBB CO2 citations62
US10745382B2Aug 18, 2020
Compounds useful as immunomodulators
BRISTOL MYERS SQUIBB CO2 citations62
US9034882B2May 19, 2015
Inhibitors of human immunodeficiency virus replication
BRISTOL MYERS SQUIBB CO3 citations62
US8906929B2Dec 9, 2014
Inhibitors of human immunodeficiency virus replication
BRISTOL MYERS SQUIBB CO2 citations62
US9758487B2Sep 12, 2017
Hepatitis C virus inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
US8343999B2Jan 1, 2013
Thiazolyl compounds useful as kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
BACHAND CAROL
6 patentsUS8574563B2Nov 5, 2013
Hepatitis C virus inhibitors
BACHAND CAROL18 citations92
US8303944B2Nov 6, 2012
Hepatitis C virus inhibitors
BACHAND CAROL36 citations92
US8147818B2Apr 3, 2012
Hepatitis C virus inhibitors
BACHAND CAROL22 citations92
US8492553B2Jul 23, 2013
Hepatitis C virus inhibitors
BACHAND CAROL11 citations84
US8288562B2Oct 16, 2012
Hepatitis C virus inhibitors
BACHAND CAROL9 citations84
US8093243B2Jan 10, 2012
Hepatitis C virus inhibitors
BACHAND CAROL5 citations62
BRISTOL MYERS CO
2 patentsVIIV HEALTHCARE UK NO 5 LTD
2 patentsUS10125148B2Nov 13, 2018
Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations41
US9932356B2Apr 3, 2018
Pyrazolopyrimidine macrocycles as inhibitors of human immunodeficiency virus replication
VIIV HEALTHCARE UK NO 5 LTD0 citations41